Improved Sensitivity in BRAFV600E Detection in Combined Tissue and Extracellular Vesicle-Based Liquid Biopsy in Melanoma

被引：2
|
作者：
Garcia-Silva, Susana [1 ]
Vico-Alonso, Cristina [2 ]
Meyer, Lisa [3 ]
Enderle, Daniel [3 ]
Sanchez, J. Aquiles [4 ]
Onteniente, Maria del Mar [2 ]
Noerholm, Mikkel [3 ]
Skog, Johan [4 ]
Rodriguez-Peralto, Jose-Luis [4 ,5 ]
Ortiz-Romero, Pablo-Luis [2 ]
Peinado, Hector [1 ]
机构：
[1] Spanish Natl Canc Res Ctr CNIO, Mol Oncol Programme, Microenvironm & Metastasis Lab, Madrid, Spain
[2] Univ Complutense, Hosp Octubre 12, Inst I 1, Ctr Invest Biomed Red Canc CIBERONC,Dept Dermatol, Madrid, Spain
[3] Exosome Diagnost, Martinsried, Germany
[4] Exosome Diagnost, Waltham, MA USA
[5] Univ Complutense, Hosp Octubre 12, Inst I 12, Ctr Invest Biomed Red Canc CIBERONC,Dept Pathol, Madrid, Spain
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 08期
关键词：
MUTANT KRAS; MUTATION; EXOSOMES; DNA;
D O I：
10.1016/j.jid.2023.01.025
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：1606 / 1610
页数：5
相关论文
共 50 条
  • [41] A Place for BRAFV600E Mutation-specific Immunohistochemistry Alongside Cell-free DNA Mutation Detection in Melanoma Reply
    Ashida, Atsuko
    Uhara, Hisashi
    Mikoshiba, Asuka
    Sakaizawa, Kaori
    Kumagai, Naomi
    Koga, Hiroshi
    Okuyama, Ryuhei
    ACTA DERMATO-VENEREOLOGICA, 2016, 96 (03) : 427 - 427
  • [42] Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trial
    Menzies, A. M.
    Ashworth, M. T.
    Swann, S.
    Kefford, R. F.
    Flaherty, K.
    Weber, J.
    Infante, J. R.
    Kim, K. B.
    Gonzalez, R.
    Hamid, O.
    Schuchter, L.
    Cebon, J.
    Sosman, J. A.
    Little, S.
    Sun, P.
    Aktan, G.
    Ouellet, D.
    Jin, F.
    Long, G. V.
    Daud, A.
    ANNALS OF ONCOLOGY, 2015, 26 (02) : 415 - 421
  • [43] Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAFV600E mutation (vol 216, pg 1061, 2019)
    Garcia-Silva, Susana
    Benito-Martin, Alberto
    Sanchez-Redondo, Sara
    Hernandez-Barranco, Alberto
    Ximenez-Embun, Pilar
    Nogues, Laura
    Mazariegos, Marina S.
    Brinkmann, Kay
    Lopez, Ana Amor
    Meyer, Lisa
    Rodriguez, Carlos
    Garcia-Martin, Carmen
    Boskovic, Jasminka
    Leton, Rocio
    Montero, Cristina
    Robledo, Mercedes
    Santambrogio, Laura
    Brady, Mary Sue
    Szumera-Cieckiewicz, Anna
    Kalinowska, Iwona
    Skog, Johan
    Noerholm, Mikkel
    Munoz, Javier
    Ortiz-Romero, Pablo L.
    Ruano, Yolanda
    Rodriguez-Peralto, Jose L.
    Rutkowski, Piotr
    Peinado, Hector
    JOURNAL OF EXPERIMENTAL MEDICINE, 2019, 216 (05): : 1230 - 1230
  • [44] Extracellular Vesicle-Based Bronchoalveolar Lavage Fluid Liquid Biopsy for EGFR Mutation Testing in Advanced Non-Squamous NSCLC
    Kim, In Ae
    Hur, Jae Young
    Kim, Hee Joung
    Kim, Wan Seop
    Lee, Kye Young
    CANCERS, 2022, 14 (11)
  • [45] Specific and Sensitive Detection of BRAFV600E Mutations in Papillary Thyroid Carcinoma by Oligonucleotide Microarray-based Fluorescence Assay
    Wei Jia
    Gao Jia-Xue
    Wang Yao-Qi
    Wang Zhen-Xin
    Meng Xian-Ying
    CHINESE JOURNAL OF ANALYTICAL CHEMISTRY, 2019, 47 (06) : 855 - 861
  • [46] BRAFV600E Gene Mutation in Colonic Adenocarcinomas. Immunohistochemical Detection Using Tissue Microarray and Clinicopathologic Characteristics: An 86 Case Series
    Boulagnon, Camille
    Dudez, Oriane
    Beaudoux, Olivia
    Dalstein, Veronique
    Kianmanesh, Reza
    Bouche, Olivier
    Diebold, Marie-Daniele
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2016, 24 (02) : 88 - 96
  • [47] Detection of cell-free circulating BRAFV600E by droplet digital polymerase chain reaction in patients with and without melanoma under dermatological surveillance
    Calbet-Llopart, N.
    Potrony, M.
    Tell-Marti, G.
    Carrera, C.
    Barreiro, A.
    Aguilera, P.
    Podlipnik, S.
    Puig, S.
    Malvehy, J.
    Puig-Butille, J. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (02) : 382 - 389
  • [48] HO-1 down-regulation increases the efficacy of BRAFV600E inhibition-based therapy in primary melanoma cells
    Furfaro, Anna Lisa
    Pietra, Gabriella
    Cossu, Irene
    Marinari, Umberto M.
    Moretta, Lorenzo
    Mingari, Maria Cristina
    Pronzato, Maria A.
    Nitti, Mariapaola
    FREE RADICAL BIOLOGY AND MEDICINE, 2017, 108 : S64 - S64
  • [49] HO-1 Down-Regulation Increases the Efficacy of BRAFV600E Inhibition-Based Therapy in Primary Melanoma Cells
    Furfaro, Anna Lisa
    Pietra, Gabriella
    Marinari, Umberto Maria
    Moretta, Lorenzo
    Mingari, Maria Cristina
    Pronzato, Maria Adelaide
    Nitti, Mariapaola
    FREE RADICAL BIOLOGY AND MEDICINE, 2016, 100 : S122 - S122
  • [50] A phase I/II trial of BKM120 combined with vemurafenib (PLX4032) in BRAFV600E/k mutant advanced melanoma.
    Kantor, Andrea
    Daud, Adil
    Munster, Pamela N.
    Ea, Roth
    Algazi, Alain Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345